Tag: NextPoint Therapeutics

NextPoint Therapeutics has filed a notice of an exempt offering of securities to raise $42,479,388.00 in New Equity Investment.

NextPoint Therapeutics has filed a notice of an exempt offering of securities to raise $42,479,388.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, NextPoint Therapeutics is raising up to $42,479,388.00 in new funding. Sources indicate that as part of senior management Secretary and Treasurer, Paul Conrad played a…

Read More Read More

NextPoint Therapeutics Announces Closing of Series B Financing Extension Led by Catalio Capital Management

NextPoint Therapeutics Announces Closing of Series B Financing Extension Led by Catalio Capital Management

Total of $122.5M Series B funding includes $42.5M Extension from new and existing investors Financing propels company to transform the potential of immunotherapy into precision oncology by leveraging HHLA2/B7-H7 for both immunomodulation and direct tumor-targeting…

Read More Read More